Keywords: glaxosmithkline, sales, growth, eps, rise, line, expectations

GlaxoSmithKline's 7% sales growth and 18% EPS rise in line with expectations

Article | 13 February 2006

Print This

The world's second-largest drugmaker by sales, GlaxoSmithKline, has posted a strong set of results for 2005, showing turnover up 7% at L21.66 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in